MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search

Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile

J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas (Santiago, Chile)

Meeting: 2024 International Congress

Abstract Number: 1470

Keywords: Behavioral abnormalities, Chorea (also see specific diagnoses, Huntingtons disease, etc): Clinical features, Depression

Category: Huntington's Disease

Objective: To describe the prevalence of motor and neuropsychiatric symptoms in HD patients seen at the Center of Movement Disorders (CETRAM), Santiago, Chile.

Background: There is limited data in Chile regarding motor and non-motor features of patients with Huntington’s disease (HD). However, it is well-established that neuropsychiatric events are present throughout the evolution of HD.

Method: This is a retrospective, descriptive study of patients with HD seen at CETRAM between 2014 and 2023. We investigated the patients’ family background, genetic tests (either personal or first-degree relative), and neuropsychiatric features. Symptoms correlated with their age of onset, were recorded. The repeat length (RL) of CAG trinucleotide expansion mutation in the HTT gene was divided into three groups: 36-42, 43-48, and 49 or above. We explored the correlation between symptoms and factors such as sex, RL, age at onset of symptoms, and years of diagnosis.

Results: The study included 70 patients with an average age of 49.44 years (SD=13.69). 62.9% were women and 37.1% were men. Maternal and Paternal inheritance was identified in 40% and 48.57% of cases, respectively. 2.86% had no family history, and 8.57% were still unknown. According to the reported information, a medical history of neuropsychiatric characteristics included depression (68.6%), irritability (77.1%), violent behavior (47.1%), apathy (67.1%), obsessive behavior (75.7%), psychosis (24.35), cognitive impairment (12.9%), previous suicidal ideation or attempts (12.9%). Motor symptoms were present in 88.6%. No statistically significant association (SSA) was found between gender and symptoms (table 1). However, there was a SSA between violence and RL (P value<0.05, Table 2). Additionally, depression, irritability, apathy, and motor symptoms had SSA with the year of HD diagnosis (table 3).

Conclusion: Neuropsychiatric symptoms are prevalent in individuals with HD. The high incidence of suicidal behavior in this cohort is noteworthy. Depression, apathy, irritability, and motor symptoms can manifest years before diagnosis, indicating a delay in treatment, genetic counseling and family support. Remarkably, individuals with a higher RL seem more susceptible to violent behavior. To establish these correlations better, we need to expand our sample size of HD patients.

Table 1

Table 1

Table 2

Table 2

Table 3

Table 3

To cite this abstract in AMA style:

J. Fuentes, P. Salles, P. Chaná-Cuevas, C. Montalva, M. Sánchez, N. Rojas. Clinical and Epidemiological Aspects of Neuropsychiatric Features in Patients with Huntington Disease in Chile [abstract]. Mov Disord. 2024; 39 (suppl 1). https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-aspects-of-neuropsychiatric-features-in-patients-with-huntington-disease-in-chile/. Accessed June 15, 2025.
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2024 International Congress

MDS Abstracts - https://www.mdsabstracts.org/abstract/clinical-and-epidemiological-aspects-of-neuropsychiatric-features-in-patients-with-huntington-disease-in-chile/

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Patients with Essential Tremor Live Longer than their Relatives
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Life expectancy with and without Parkinson’s disease in the general population
  • The hardest symptoms that bother patients with Parkinson's disease
  • An Apparent Cluster of Parkinson's Disease (PD) in a Golf Community
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley